 | • レポートコード：MRC2304L049 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、230ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、世界の幹細胞アッセイ市場規模が2021年に1,852.11百万ドル、2022年に2,259.29百万ドルとなり、その後2027年までにCAGR 22.23％で成長して6,179.13百万ドルに達すると予測しています。当書は、幹細胞アッセイの世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（器具、試薬＆キット）、アッセイ別分析（アポトーシスアッセイ、細胞同定アッセイ、分離＆精製アッセイ、生存率/細胞毒性アッセイ）、用途別分析（臨床研究、創薬＆開発、再生医療＆治療）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。また、当書には、Astellas Pharma Inc.、Bio-Rad Laboratories, Inc.、BioTime, Inc.、Biovault Family Ltd.、Caladrius Biosciences, Inc.、Celgene Corporation、Cell Biolabs, Inc.、Cellular Engineering Technologies、HemoGenix, Inc.、Mesoblast Ltdなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の幹細胞アッセイ市場規模：製品別 - 器具の市場規模 - 試薬＆キットの市場規模 ・世界の幹細胞アッセイ市場規模：アッセイ別 - アポトーシスアッセイの市場規模 - 細胞同定アッセイの市場規模 - 分離＆精製アッセイの市場規模 - 生存率/細胞毒性アッセイの市場規模 ・世界の幹細胞アッセイ市場規模：用途別 - 臨床研究における市場規模 - 創薬＆開発における市場規模 - 再生医療＆治療における市場規模 ・世界の幹細胞アッセイ市場規模：地域別 - 南北アメリカの幹細胞アッセイ市場規模 アメリカの幹細胞アッセイ市場規模 カナダの幹細胞アッセイ市場規模 ブラジルの幹細胞アッセイ市場規模 ... - アジア太平洋の幹細胞アッセイ市場規模 日本の幹細胞アッセイ市場規模 中国の幹細胞アッセイ市場規模 インドの幹細胞アッセイ市場規模 韓国の幹細胞アッセイ市場規模 台湾の幹細胞アッセイ市場規模 ... - ヨーロッパ/中東/アフリカの幹細胞アッセイ市場規模 イギリスの幹細胞アッセイ市場規模 ドイツの幹細胞アッセイ市場規模 フランスの幹細胞アッセイ市場規模 ロシアの幹細胞アッセイ市場規模 ... - その他地域の幹細胞アッセイ市場規模 ・競争状況 ・企業情報 |
The Global Stem Cell Assays Market size was estimated at USD 1,852.11 million in 2021 and expected to reach USD 2,259.29 million in 2022, and is projected to grow at a CAGR 22.23% to reach USD 6,179.13 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Stem Cell Assays to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Instruments and Reagents & Kits.
Based on Assay, the market was studied across Apoptosis Assays, Cell Identification Assays, Isolation & Purification Assays, and Viability or Cytotoxicity Assays.
Based on Application, the market was studied across Clinical Research, Drug Discovery & Development, and Regenerative Medicine & Therapy.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Stem Cell Assays market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Stem Cell Assays Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Stem Cell Assays Market, including Astellas Pharma Inc., Bio-Rad Laboratories, Inc., BioTime, Inc., Biovault Family Ltd., Caladrius Biosciences, Inc., Celgene Corporation, Cell Biolabs, Inc., Cellular Engineering Technologies, HemoGenix, Inc., Mesoblast Ltd, Miltenyi Biotec GmbH, Opexa Therapeutics, Inc., PerkinElmer, Inc., Pluristem Therapeutics Inc, Precious Cells International Ltd, Precision Cellular Storage Ltd., ReNeuron Group PLC, Seneca Biopharmaceuticals, Inc., STEMCELL Technologies Inc., and ThermoGenesis Holdings, Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Stem Cell Assays Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Stem Cell Assays Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Stem Cell Assays Market?
4. What is the competitive strategic window for opportunities in the Global Stem Cell Assays Market?
5. What are the technology trends and regulatory frameworks in the Global Stem Cell Assays Market?
6. What is the market share of the leading vendors in the Global Stem Cell Assays Market?
7. What modes and strategic moves are considered suitable for entering the Global Stem Cell Assays Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness about therapeutic potency of stem cells
5.1.1.2. Rising funding for stem cell research globally
5.1.1.3. Growing demand for cell-based assays in drug discovery
5.1.2. Restraints
5.1.2.1. Issues in embryonic stem cell research
5.1.3. Opportunities
5.1.3.1. Availability of funding and grants to support the clinical research on stem cells
5.1.3.2. Development and launch of new stem cell analysis systems
5.1.4. Challenges
5.1.4.1. Lack of infrastructure for stem cell research in emerging economies
5.1.4.2. Dearth of trained and skilled professionals
5.2. Cumulative Impact of COVID-19
6. Stem Cell Assays Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents & Kits
7. Stem Cell Assays Market, by Assay
7.1. Introduction
7.2. Apoptosis Assays
7.3. Cell Identification Assays
7.4. Isolation & Purification Assays
7.5. Viability or Cytotoxicity Assays
8. Stem Cell Assays Market, by Application
8.1. Introduction
8.2. Clinical Research
8.3. Drug Discovery & Development
8.4. Regenerative Medicine & Therapy
9. Americas Stem Cell Assays Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Stem Cell Assays Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Stem Cell Assays Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Astellas Pharma Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Bio-Rad Laboratories, Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. BioTime, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Biovault Family Ltd.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Caladrius Biosciences, Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Celgene Corporation
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Cell Biolabs, Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Cellular Engineering Technologies
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. HemoGenix, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Mesoblast Ltd
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Miltenyi Biotec GmbH
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Opexa Therapeutics, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. PerkinElmer, Inc.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Pluristem Therapeutics Inc
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Precious Cells International Ltd
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Precision Cellular Storage Ltd.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. ReNeuron Group PLC
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Seneca Biopharmaceuticals, Inc.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. STEMCELL Technologies Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. ThermoGenesis Holdings, Inc
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing